LeadByAnimals
reacted to
$Predictive Oncology (POAI.US)$ Love seeing posts “No one will teach you” So i guess when i decide to post lvls. Its only for my benefit??? Hehehe. I already know what im looking for! I post to help others maybe make a decision ifn they want to use those lvls as well! And my lvls are usually spot on! Hehehe. But yeah there is NO ONE that really tries to help others! LMAO So cynical! Hehehe
24
12
LeadByAnimals
commented on
$ConnectM Technology Solutions (CNTM.US)$ Another 13G filed. 3 mil shares
1
LeadByAnimals
reacted to
$Plus Therapeutics (PSTV.US)$ As i said to my Brother @Jaguar8 in early PM! This gets a FDA approval for a Proprietary Name ( Conditionally ) for a drug mind you thats still waiting for actual NDA approval! And its making such a HUGE move up! (( Again great )) But we see companies just in the last few weeks that actually get FDA approval to move forward. And they hardly move. Or move and then fall all day long after initial spike up! Hehehe! FOOD...
2
5
LeadByAnimals
reacted to and commented on
$scPharmaceuticals (SCPH.US)$ scPharmaceuticals Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
scPharmaceuticals generated fourth quarter 2024 net FUROSCIX® revenue of $12.2 million, and full year 2024 revenue of $36.3 million
Cash and cash equivalents of $75.7 million as of December 31, 2024
U.S. Food and Drug Administration (FDA) approved the FUROSCIX expanded label indication to include the treatment of edema due to fluid overloa...
scPharmaceuticals generated fourth quarter 2024 net FUROSCIX® revenue of $12.2 million, and full year 2024 revenue of $36.3 million
Cash and cash equivalents of $75.7 million as of December 31, 2024
U.S. Food and Drug Administration (FDA) approved the FUROSCIX expanded label indication to include the treatment of edema due to fluid overloa...
2
2
LeadByAnimals
liked
$Scienture Holdings (SCNX.US)$ For me, i am and will continue to be bullish here for now! This FDA approval make the first and only ready to use oral liquid LOSARTAN in the USA! This represents almost 300 million is sales from about 68 million scrpits a year! No more crushing tablets. Or compounding. Which causes dosing errors and stability issues! I believe this will quickly become the preferred way to prescribe this medication for HYPERTENSION and a few other ailmen...
8
2
LeadByAnimals
reacted to
$Bridger Aerospace (BAER.US)$ I dig this earnings so much. Ima start swingin this! Hehehe. Market been rough for swinging lately. But ima do it and you cant stop me! Hehehe. NFA Just thinking outloud!
2
LeadByAnimals
reacted to
$Vast Renewables (VSTE.US)$ FINTEL is now at ZERO LTB! The nakeds will be coming and if volume stays high? I will throw it out there now! MM’s by 10:30 will be sending 50%+ of open market volume off exchange to try and hold it down! Hehehe
3
4
LeadByAnimals
liked
Hey mooer! Attention AI enthusiasts, $NVIDIA (NVDA.US)$ GTC 2025 is coming! 🚀
NVIDIA GTC 2025 is returning to San Jose from March 17-21, bringing together industry leaders to explore the future of quantum computing and AI. This premier event offers a unique opportunity to dive deep into cutting-edge technologies that are shaping our future.
Highlights:
– Keynote speech by NVIDIA CEO Jensen Huang (March 18, 10:00 a.m. PT) on the topic "Driving t...
NVIDIA GTC 2025 is returning to San Jose from March 17-21, bringing together industry leaders to explore the future of quantum computing and AI. This premier event offers a unique opportunity to dive deep into cutting-edge technologies that are shaping our future.
Highlights:
– Keynote speech by NVIDIA CEO Jensen Huang (March 18, 10:00 a.m. PT) on the topic "Driving t...
GTC Keynote With NVIDIA CEO Jensen Huang
Mar 19 01:00
368
340
61
![[empty]](https://static.moomoo.com/node_futunn_nnq/assets/images/folder.5c37692712.png)
![[error]](https://static.moomoo.com/node_futunn_nnq/assets/images/no-network.991ae8055c.png)
![[loading]](data:image/svg+xml;base64,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)